Physician profile
Robert M Weingart
NPI 1124091616
$860.90
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $490 · 2020: $72.73 · 2021: $298.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $283.22 | 2021 | |
| Astellas Pharma US INC | $148.39 | 2019 | |
| Pfizer INC. | $73.93 | 2019-2021 | |
| Janssen Biotech, INC. | $72.07 | 2019-2020 | |
| Abbvie INC. | $48.42 | 2019-2020 | |
| Antares Pharma, INC. | $42.61 | 2019 | |
| Dendreon Pharmaceuticals LLC | $30.75 | 2019 | |
| Boston Scientific Corporation | $25.70 | 2020 | |
| Travere Therapeutics, INC. | $20.68 | 2019 | |
| Tersera Therapeutics LLC | $18.31 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.89 | 2019 | |
| Zyla Life Sciences, INC. | $15.49 | 2019 | |
| Melinta Therapeutics, LLC | $14.40 | 2019 | |
| C. R. Bard, INC. & Subsidiaries | $13.66 | 2019 | |
| Allergan, INC. | $12.52 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $12.48 | 2019 | |
| Cook Medical LLC | $12.38 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Weingart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.